Spatially-offset Raman spectroscopy for the non-invasive, real-time characterization of in situ skin implant formation and drug release kinetics

In situ forming implants (ISFIs) present a promising approach for sustained parenteral drug delivery, offering reduced first pass metabolism, fewer systemic side effects, and improved patient compliance. This study investigates defocused spatially-offset Raman spectroscopy (SORS) as a real-time, non-invasive, and label-free method for monitoring implant formation and drug release from ISFIs loaded with the model drugs 4-cyanophenol (4-CP) or all-trans retinoic acid (RA). A custom-designed flow-through diffusion cell, incorporating full-thickness porcine skin, was developed to enable ex vivo release studies, allowing simultaneous defocused SORS measurements of subcutaneously-implanted formulations and HPLC quantification of drug released into the receptor medium. Confocal Raman microscopy cross-section imaging validated defocused SORS findings, while static ex vivo release studies using Franz diffusion cells served as a reference for flow-through experiments. Both Franz cell and flow-through release studies revealed a pronounced burst release for the hydrophilic 4-CP after injection (90.7 % and 94.8 % released after 2.5 d under static and flow-through conditions, respectively) and a delayed, attenuated release for the hydrophobic RA (3.3 % and 2.1 % after 2.5 d). Defocused SORS further confirmed a correlation between implant formation and drug release, highlighting solvent exchange as a key driver of burst release. These findings demonstrate the unique capability of defocused SORS for the comprehensive, non-invasive, and real-time characterization of ISFI formulations. By combining the relevance of biological tissue with experimental accessibility, the ex vivo flow-through configuration (enhanced by defocused SORS) provides a novel and powerful platform for formulation development and individualized therapeutic drug monitoring, with strong potential for clinical translation.

Authors

Institutions

Publication Details

Journal
Journal of Controlled Release
Published
2025-08-30
DOI
https://doi.org/10.1016/j.jconrel.2025.114182
Citations
5
Primary Topic
Spectroscopy Techniques in Biomedical and Chemical Research
Type
article
Field-Weighted Citation Impact
8.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Spatially-offset Raman spectroscopy for the non-invasive, real-time characterization of in situ skin implant formation and drug release kinetics

Kārlis Bērziņš, Maximilian Rath, Ben J. Boyd, Andrea Heinz
5 citations
Journal of Controlled Release
Spectroscopy Techniques in Biomedical and Chemical Research
8.17
article

Spatially-offset Raman spectroscopy for the non-invasive, real-time characterization of in situ skin implant formation and drug release kinetics

Kārlis Bērziņš, Maximilian Rath, Ben J. Boyd, Andrea Heinz
article en
5 citations

Abstract

In situ forming implants (ISFIs) present a promising approach for sustained parenteral drug delivery, offering reduced first pass metabolism, fewer systemic side effects, and improved patient compliance. This study investigates defocused spatially-offset Raman spectroscopy (SORS) as a real-time, non-invasive, and label-free method for monitoring implant formation and drug release from ISFIs loaded with the model drugs 4-cyanophenol (4-CP) or all-trans retinoic acid (RA). A custom-designed flow-through diffusion cell, incorporating full-thickness porcine skin, was developed to enable ex vivo release studies, allowing simultaneous defocused SORS measurements of subcutaneously-implanted formulations and HPLC quantification of drug released into the receptor medium. Confocal Raman microscopy cross-section imaging validated defocused SORS findings, while static ex vivo release studies using Franz diffusion cells served as a reference for flow-through experiments. Both Franz cell and flow-through release studies revealed a pronounced burst release for the hydrophilic 4-CP after injection (90.7 % and 94.8 % released after 2.5 d under static and flow-through conditions, respectively) and a delayed, attenuated release for the hydrophobic RA (3.3 % and 2.1 % after 2.5 d). Defocused SORS further confirmed a correlation between implant formation and drug release, highlighting solvent exchange as a key driver of burst release. These findings demonstrate the unique capability of defocused SORS for the comprehensive, non-invasive, and real-time characterization of ISFI formulations. By combining the relevance of biological tissue with experimental accessibility, the ex vivo flow-through configuration (enhanced by defocused SORS) provides a novel and powerful platform for formulation development and individualized therapeutic drug monitoring, with strong potential for clinical translation.

Journal of Controlled ReleaseVol. 387
University of Copenhagen (DK), LEO Foundation (DK)
Novo Nordisk, Novo Nordisk Fonden, LEO Fondet
Zero hunger
Openalex Percentile: Top 3%
Spectroscopy Techniques in Biomedical and Chemical Research
8.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.